Description
| Method: | ECLIA, FMF Certified |
| Comment: | For Combined Risk Assessment (Biochemical risk + Nuchal translucency) kindly enclose Ultrasound report between 11-13 weeks + 6 days gestation including CRL, NT & Nasal Bone. |
| Price: | 2250.00 |
| Report: | Sample Mon through Sat by 11 am; Report Same day |
| Usage: | Aneuploidies are major causes of perinatal death and childhood handicap. Maternal serum screening test is an effective screening method for detection of major aneuploidies like Trisomy 21 & Trisomy 18/13 in the first trimester of pregnancy. Detection rate for Down syndrome is 60% with a false positive rate of 5% if only biochemical risk is estimated. A combination of Nuchal translucency and biochemical tests (Combined test) has detection rate of Down syndrome 82 to 87% at 5% false positive rate. Addition of absent nasal bone status can improve detection rate up to 93% at false positive rate of 2.5%. |
| Doctor Specialty: | Gynecologist |
| Disease: | Prenatal Diagnosis |
| Components: | *PAPP-A *Free Beta HCG *Risk Evaluation |
| Courier Charges: | 0.00 |
| Home Collection: | Available |
| Department: | IMMUNOASSAY |
| Pre Test Information: | Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Acceptable between 9 to 13 weeks + 6 days gestation. |